Market Launch of First Factor Xa Reversal Agent in European Countries
[et_pb_section fb_built="1" _builder_version="3.22.3"][et_pb_row…
Syphilitic Vasculitis: a mysterious and dangerous cause of stroke in the young
[et_pb_section fb_built="1" _builder_version="3.22.3"][et_pb_row…
Bundle of care to improve outcomes after intracerebral haemorrhage: as easy as ABC?
[et_pb_section fb_built="1" _builder_version="3.22.3"][et_pb_row…
Is it all about genes?
[et_pb_section fb_built="1" _builder_version="3.22.3"][et_pb_row…
Neurotechnology Improves Upper Limb Motor Rehabilitation in Severe Chronic Stroke
[et_pb_section fb_built="1" _builder_version="3.22.3"][et_pb_row…
Sometimes Age Doesn’t Matter
[et_pb_section fb_built="1" _builder_version="3.22.3"][et_pb_row…
Genealogy of Aneurysms
[et_pb_section fb_built="1" _builder_version="3.22.3"][et_pb_row…
Tenecteplase – a new hope?
Alteplase is the cornerstone of acute ischemic stroke pharmacological treatment, either alone or prior to mechanical thrombectomy.
An upcoming crossroad: should vascular neurologists become more intensivists?
[et_pb_section fb_built="1" _builder_version="3.22.3"][et_pb_row…